News

Health | 19 February, 2019

Four academics named among UK's 25 most influential researchers studying diabetes complications

Four Queen's University Belfast academics have been named among the UK's most influential researchers who study diabetes complications.

Queen's was ranked fourth among the top institutions for diabetes complications.

The 'Leaders in Diabetes Complications' list is based on the impact of the research published by the authors and is part of a new Diabetes Times series.

The Diabetes Times partnered with Expertscape, the world's leading index of academic achievement and expertise in healthcare, to highlight the UK's leading diabetes experts.

The following Queen's researchers were recognised in the list:

˃  Professor Alan Stitt – Dean of Innovation and Impact, School of Medicine, Dentistry and Biomedical Sciences

˃  Professor Tunde Peto – Clinical Professor, School of Medicine, Dentistry and Biomedical Sciences

˃  Dr Amy Jayne McKnight – Reader, School of Medicine, Dentistry and Biomedical Sciences

˃  Professor Usha Chakravarthy – School of Medicine, Dentistry and Biomedical Sciences

To arrive at its rankings, Expertscape bases the results on scientific publications.

Professor Tunde Peto, Clinical Professor in the School of Medicine, Dentistry and Biomedical Sciences, said:

"Diabetes UK reports that one in 15 people in the UK have diabetes, including one million people who have Type 2, but haven't been diagnosed. At Queen's we are committed to better understanding this disease and its complications in order to develop innovative treatments and enhanced care that improves the lives of people with diabetes. It is therefore wonderful to see the impactfulness of our research on diabetes complications so resoundingly recognised – to have four academics listed among the UK's leading diabetes experts and to rank fourth in the list of top institutions for this type of research is a real honour."

Commenting on the 'Leaders in Diabetes Complications' list, Brendan McAdams, Managing Partner of Expertscape, said: "It's great to see such a concentration of knowledge in the UK, which is a testament to the research and treatment being done here. We are proud to be working with the Diabetes Times on this, and our compliments and thanks go out to the leading impactors and institutions in the UK for their effort and accomplishment in the field of diabetes."